Tumor necrosis factor α promotes invasiveness of cholangiocarcinoma cells via its receptor, TNFR2

被引:48
作者
Tanimura, Y
Kokuryo, T
Tsunoda, N
Yamazaki, Y
Oda, K
Nimura, Y
Mon, NN
Huang, PY
Nakanuma, Y
Chen, MF
Jan, YY
Yeh, TS
Chiu, CT
Hsieh, LL
Hamaguchi, M
机构
[1] Nagoya Univ, Grad Sch Med, Div Canc Biol, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol,Showa Ku, Nagoya, Aichi 4668550, Japan
[3] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208641, Japan
[4] Chang Gumg Univ, Mem Hosp, Dept Surg, Taipei 105, Taiwan
[5] Chang Gumg Univ, Mem Hosp, Dept Gastroenterol, Taipei 105, Taiwan
[6] Chang Gumg Univ, Mem Hosp, Dept Publ Hlth, Taipei 105, Taiwan
关键词
cholangiocarcinoma; matrix metalloproteinase; tumor necrosis factor-alpha; invasion;
D O I
10.1016/j.canlet.2004.07.027
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We studied the effect of TNF-alpha stimulation on a cholangiocarcinoma cell line, CCKS1. CCKS1 expressed only one type TNF receptor,TNFR2. Treatment of CCKS1 with TNF-a substantially activated NF kappa B, MAPK and Akt signalings which in turn activated matrix metalloproteinase-9 (MMP-9) secretion and in vitro invasiveness of CCKS1. Pretreatment of cells with anti-TNFR2 neutralizing antibody inhibited the TNF-alpha-dependent signaling and MMP-9 secretion and subsequently blocked invasion in vitro. Moreover, an inhibitor for matrix metalloproteinase, Galardin, suppressed the invasion in a dose-dependent manner. Similarly, pharmacological inhibition of signaling clearly suppressed the TNF-alpha dependent MMP-9 secretion. These results strongly suggest that TNF-alpha-TNFR2 signaling plays an important role to convert the cholangiocarcinoma cells to be more aggressive one. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:205 / 213
页数:9
相关论文
共 32 条
[11]   P60(V-SRC) CAUSES TYROSINE PHOSPHORYLATION AND INACTIVATION OF THE N-CADHERIN CATENIN CELL-ADHESION SYSTEM [J].
HAMAGUCHI, M ;
MATSUYOSHI, N ;
OHNISHI, Y ;
GOTOH, B ;
TAKEICHI, M ;
NAGAI, Y .
EMBO JOURNAL, 1993, 12 (01) :307-314
[12]  
HAMAGUCHI M, 1995, ONCOGENE, V10, P1037
[13]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70
[14]  
Hayashi K, 2001, CANCER RES, V61, P2361
[15]  
HIGUCHI M, 1994, J IMMUNOL, V152, P3550
[16]  
Kokuryo T, 2003, INT J ONCOL, V22, P175
[17]   HEPATOLITHIASIS ASSOCIATED WITH CHOLANGIOCARCINOMA [J].
KUBO, S ;
KINOSHITA, H ;
HIROHASHI, K ;
HAMBA, H .
WORLD JOURNAL OF SURGERY, 1995, 19 (04) :637-641
[18]  
Liu EB, 2000, CANCER RES, V60, P2361
[19]   Differential activation of nuclear factor-κB by tumour necrosis factor receptor subtypes.: TNFR1 predominates whereas TNFR2 activates transcription poorly [J].
McFarlane, SM ;
Pashmi, G ;
Connell, MC ;
Littlejohn, AF ;
Tucker, SJ ;
Vandenabeele, P ;
MacEwan, DJ .
FEBS LETTERS, 2002, 515 (1-3) :119-126
[20]   Role of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice [J].
Mizoguchi, E ;
Mizoguchi, A ;
Takedatsu, H ;
Cario, E ;
De Jong, YP ;
Ooi, CJ ;
Xavier, RJ ;
Terhorst, C ;
Podolsky, DK ;
Bhan, AK .
GASTROENTEROLOGY, 2002, 122 (01) :134-144